Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitie Regulatory News (MTO)

Share Price Information for Mitie (MTO)

Share Price is delayed by 15 minutes
Get Live Data
165.00    -5.20 (-3.06%)
Bid:
164.90
Ask:
165.10
Spread: 0.20 (0.121%)
Market Cap: £2.07b
MTO Live PriceLast checked at - London Stock Exchange

Intraday Mitie Share Chart

Form 8.3 MITIE GROUP PLC

18 Jun 2025 14:33

RNS Number : 4388N
Barclays PLC
18 June 2025
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

MITIE GROUP PLC

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

17 Jun 2025

(f)

In addition to the company in 1(c) above, is the discloser making

YES:

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

MARLOWE PLC

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

2.5p ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

20,124,227

1.60%

2,095,314

0.17%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

1,036,509

0.08%

12,103,769

0.96%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

21,160,736

1.68%

14,199,083

1.13%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

2.5p ordinary

Purchase

132,110

1.4316 GBP

2.5p ordinary

Purchase

129,947

1.4320 GBP

2.5p ordinary

Purchase

82,432

1.4311 GBP

2.5p ordinary

Purchase

56,894

1.4296 GBP

2.5p ordinary

Purchase

48,232

1.4319 GBP

2.5p ordinary

Purchase

35,822

1.4300 GBP

2.5p ordinary

Purchase

33,915

1.4305 GBP

2.5p ordinary

Purchase

18,134

1.4310 GBP

2.5p ordinary

Purchase

13,809

1.4260 GBP

2.5p ordinary

Purchase

10,622

1.4290 GBP

2.5p ordinary

Purchase

10,000

1.4307 GBP

2.5p ordinary

Purchase

9,467

1.4289 GBP

2.5p ordinary

Purchase

3,334

1.4232 GBP

2.5p ordinary

Purchase

3,018

1.4222 GBP

2.5p ordinary

Purchase

2,572

1.4292 GBP

2.5p ordinary

Purchase

1,845

1.4283 GBP

2.5p ordinary

Purchase

1,112

1.4280 GBP

2.5p ordinary

Purchase

587

1.4285 GBP

2.5p ordinary

Purchase

373

1.4180 GBP

2.5p ordinary

Sale

280,121

1.4295 GBP

2.5p ordinary

Sale

218,064

1.4320 GBP

2.5p ordinary

Sale

144,658

1.4312 GBP

2.5p ordinary

Sale

80,641

1.4304 GBP

2.5p ordinary

Sale

39,856

1.4299 GBP

2.5p ordinary

Sale

30,667

1.4286 GBP

2.5p ordinary

Sale

28,587

1.4303 GBP

2.5p ordinary

Sale

23,664

1.4224 GBP

2.5p ordinary

Sale

16,964

1.4281 GBP

2.5p ordinary

Sale

9,182

1.4279 GBP

2.5p ordinary

Sale

6,813

1.4280 GBP

2.5p ordinary

Sale

4,164

1.4243 GBP

2.5p ordinary

Sale

2,786

1.4202 GBP

2.5p ordinary

Sale

864

1.4255 GBP

2.5p ordinary

Sale

735

1.4294 GBP

2.5p ordinary

Sale

373

1.4180 GBP

2.5p ordinary

Sale

310

1.4313 GBP

2.5p ordinary

Sale

149

1.4200 GBP

2.5p ordinary

Sale

109

1.4300 GBP

2.5p ordinary

Sale

26

1.4210 GBP

2.5p ordinary

Sale

23

1.4190 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

2.5p ordinary

SWAP

Decreasing Short

23,664

1.4224 GBP

2.5p ordinary

SWAP

Decreasing Short

151

1.4259 GBP

2.5p ordinary

SWAP

Decreasing Short

249

1.4260 GBP

2.5p ordinary

SWAP

Decreasing Short

9,182

1.4279 GBP

2.5p ordinary

SWAP

Decreasing Short

4,226

1.4280 GBP

2.5p ordinary

SWAP

Decreasing Short

27,629

1.4285 GBP

2.5p ordinary

SWAP

Decreasing Short

181,476

1.4289 GBP

2.5p ordinary

SWAP

Decreasing Short

19,256

1.4292 GBP

2.5p ordinary

SWAP

Decreasing Short

3,038

1.4293 GBP

2.5p ordinary

SWAP

Decreasing Short

52,951

1.4295 GBP

2.5p ordinary

SWAP

Decreasing Short

38,136

1.4308 GBP

2.5p ordinary

SWAP

Increasing Short

2,928

1.4222 GBP

2.5p ordinary

SWAP

Increasing Short

90

1.4240 GBP

2.5p ordinary

SWAP

Increasing Short

9,297

1.4295 GBP

2.5p ordinary

SWAP

Increasing Short

56,894

1.4296 GBP

2.5p ordinary

SWAP

Increasing Short

6,083

1.4298 GBP

2.5p ordinary

SWAP

Increasing Short

10,748

1.4304 GBP

2.5p ordinary

SWAP

Increasing Short

33,915

1.4305 GBP

2.5p ordinary

SWAP

Increasing Short

17,788

1.4307 GBP

2.5p ordinary

SWAP

Increasing Short

137,238

1.4320 GBP

2.5p ordinary

CFD

Decreasing Short

14,812

1.4240 GBP

2.5p ordinary

CFD

Decreasing Short

12,801

1.4280 GBP

2.5p ordinary

CFD

Decreasing Short

6,906

1.4296 GBP

2.5p ordinary

CFD

Decreasing Short

7,825

1.4300 GBP

2.5p ordinary

CFD

Increasing Short

20,093

1.4303 GBP

2.5p ordinary

CFD

Increasing Short

5,924

1.4320 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercising

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

18 Jun 2025

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETBXGDLDDBDGUI
Date   Source Headline
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20264:30 pmRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:05 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSQ3 FY26 Trading Update
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20264:30 pmRNSDirector/PDMR Shareholding
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20264:30 pmRNSHolding(s) in Company
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20264:30 pmRNSDirector/PDMR Shareholding
2nd Jan 20264:30 pmRNSTotal Voting Rights
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20254:30 pmRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20254:45 pmRNSTotal Voting Rights
27th Nov 20254:30 pmRNSHolding(s) in Company
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 202512:40 pmRNSDirector/PDMR Shareholding
21st Nov 202510:35 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.